Technology | 2022.07.25
Rona Therapeutics Announces Exclusive Licensing Transaction from Sanofi for its Broad siRNA Therapeutic Portfolio and Technology Platform
Rona to advance worldwide development of Sanofi siRNA portfolio targeting liver and other tissues Rona licensed Sanofi\'s siRNA platform to enable discovery programs in expanded therapeutic areas including neuro and muscular diseases, for which Sanofi has an exclusive option to acquire...
For more information, please visit
https://www.prnewswire.com:443/news-rele[...]nology-platform-301591673.html
